In need of a positive change.
Access to protons. This retrospective look at COG trial enrollees reveals Black pediatric patients are roughly one-third as likely to receive proton therapy as non-Hispanic White patients. | Bitterman, JAMA Oncol 2020
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Access to protons. This retrospective look at COG trial enrollees reveals Black pediatric patients are roughly one-third as likely to receive proton therapy as non-Hispanic White patients. | Bitterman, JAMA Oncol 2020
Comments
Post a Comment